Summary
Thermo Fisher Scientific Inc. reported solid financial results for the quarter ending July 2, 2016. Total revenues increased by 6% year-over-year to $4.54 billion, driven by growth across all segments, particularly Life Sciences Solutions and Laboratory Products and Services. Operating income also saw a healthy increase of 7% to $638 million, reflecting effective cost management and productivity improvements. The company continues its strategic acquisition path, announcing plans to acquire FEI Company for approximately $4.2 billion, further strengthening its Analytical Instruments segment. This follows the recent acquisition of Affymetrix, Inc. for $1.34 billion. These strategic moves highlight Thermo Fisher's commitment to expanding its market leadership and technological capabilities, which is expected to drive future growth and shareholder value.
Financial Highlights
56 data points| Revenue | $4.54B |
| Cost of Revenue | $2.04B |
| Gross Profit | $2.08B |
| R&D Expenses | $182.40M |
| SG&A Expenses | $1.22B |
| Operating Expenses | $3.90B |
| Operating Income | $637.60M |
| Interest Expense | $118.80M |
| Net Income | $517.00M |
| EPS (Basic) | $1.31 |
| EPS (Diluted) | $1.30 |
| Shares Outstanding (Basic) | 393.90M |
| Shares Outstanding (Diluted) | 396.70M |
Key Highlights
- 1Total revenues increased by 6% to $4.54 billion for the quarter ended July 2, 2016, compared to the prior year period.
- 2Operating income grew by 7% to $638 million, indicating improved profitability and operational efficiency.
- 3The company announced a significant acquisition of FEI Company for $4.2 billion, expanding its Analytical Instruments segment.
- 4Life Sciences Solutions and Laboratory Products and Services segments showed strong revenue growth, up 13% and 6% respectively.
- 5Net income for the quarter was $516.6 million, a slight increase from $511.6 million in the same period last year.
- 6Cash flow from operating activities for the six months ended July 2, 2016, increased significantly to $1.18 billion from $845 million in the prior year period.